T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis

Tuberculosis

Volumn 91, Issue 4, 2011, Pages 308-313

  Henao Tamayo, Marcela ^a   Irwin, Scott M ^a   Shang, Shaobin ^a   Ordway, Diane ^a   Orme, Ian M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Biomarkers; Chemotherapy; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; CD27 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; ISONIAZID; KIDNEY INJURY MOLECULE 1; L SELECTIN; LEUKOSIALIN; LYMPHOCYTE RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KLRG 1; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; BACTERIAL LOAD; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, VIRUS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 79960206717     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2011.04.001     Document Type: Article

References (30)

1. C. Lienhardt, A. Vernon, and M.C. Raviglione New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes Curr Opin Pulm Med 16 2010 186 193
2. World Health Organization Anti-Tuberculosis drug resistance in the world Report #4 2008
3. A.M. Ginsberg, and M. Spigelman Challenges in tuberculosis drug research and development Nat Med 13 2007 290 294 (Pubitemid 46376672)
4. R.S. Wallis, M. Pai, D. Menzies, T.M. Doherty, G. Walzl, and M.D. Perkins Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice Lancet 375 2010 1920 1937
5. G. Walzl, K. Ronacher, J.F. Djoba Siawaya, and H.M. Dockrell Biomarkers for TB treatment response: challenges and future strategies J Infect 57 2008 103 109
6. J.F. Djoba Siawaya, N.B. Bapela, K. Ronacher, H. Veenstra, M. Kidd, and R. Gie Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response J Infect 56 2008 340 347
7. B.P. Kelly, S.K. Furney, M.T. Jessen, and I.M. Orme Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis Antimicrob Agents Chemother 40 1996 2809 2812 (Pubitemid 26404349)
8. I.M. Orme Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection J Immunol 140 1988 3589 3593
9. L. Golden-Mason, B.E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, and B.J. McMahon Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells J Virol 83 2009 9122 9130
10. W.D. Hastings, D.E. Anderson, N. Kassam, K. Koguchi, E.A. Greenfield, and S.C. Kent TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines Eur J Immunol 39 2009 2492 2501
11. H.T. Jin, A.C. Anderson, W.G. Tan, E.E. West, S.J. Ha, and K. Araki Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection PNAS 107 2010 14733 14738
12. S. Sarkar, V. Kalia, W.N. Haining, B.T. Konieczny, S. Subramaniam, and R. Ahmed Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates J Exp Med 205 2008 625 640 (Pubitemid 351439309)
13. K.E. Brown, G.J. Freeman, E.J. Wherry, and A.H. Sharpe Role of PD-1 in regulating acute infections Curr Opin Immunol 22 2010 397 401
14. L.M. Francisco, P.T. Sage, and A.H. Sharpe The PD-1 pathway in tolerance and autoimmunity Immunol Rev 236 2010 219 242
15. S. Wang, and L. Chen Immunobiology of cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways Curr Top Microb Immunol 2010 [E-published]
16. E. Lazar-Molnar, B. Chen, K.A. Sweeney, E.J. Wang, W. Liu, and J. Lin Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis PNAS 107 2010 13402 13407
17. E.J. Wherry, S.J. Ha, S.M. Kaech, W.N. Haining, S. Sarkar, and V. Kalia Molecular signature of CD8+ T cell exhaustion during chronic viral infection Immunity 27 2007 670 684 (Pubitemid 47615511)
18. C. Zhu, A.C. Anderson, A. Schubart, H. Xiong, J. Imitola, and S.J. Khoury The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat Immunol 6 2005 1245 1252 (Pubitemid 43045636)
19. C. Zhu, A.C. Anderson, and V.K. Kuchroo TIM-3 and its Regulatory role in immune responses Curr Top Microbiol Immunol 2010 E-published
20. P.L. Lin, S. Pawar, A. Myers, A. Pegu, C. Fuhrman, and T.A. Reinhart Early events in Mycobacterium tuberculosis infection in cynomolgus macaques Infect Immun 74 2006 3790 3803 (Pubitemid 43993310)
21. S.D. Chakravarty, J. Xu, B. Lu, C. Gerard, J. Flynn, and J. Chan The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice J Immunol 178 2007 1723 1735 (Pubitemid 46154644)
22. P. Seiler, P. Aichele, S. Bandermann, A.E. Hauser, B. Lu, and N.P. Gerard Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines Eur J Immunol 33 2003 2676 2686 (Pubitemid 37337133)
23. S. Pokkali, S.D. Das, and R L Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions Cytokine 41 2008 307 314 (Pubitemid 351308157)
24. B. Vesosky, E.K. Rottinghaus, P. Stromberg, J. Turner, and G. Beamer CCL5 p.rticipates in early protection against Mycobacterium tuberculosis J Leukoc Biol 87 2010 1153 1165
25. H.M. Algood, P.L. Lin, and J.L. Flynn Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis Clin Infect Dis 41 Suppl. 3 2005 S189 S193
26. S. Brahmbhatt, G.F. Black, N.M. Carroll, N. Beyers, F. Salker, and M. Kidd Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy Clin Exp Immunol 146 2006 243 252
27. J.F. Djoba Siawaya, N.N. Chegou, M.M. van den Heuvel, A.H. Diacon, N. Beyers, and P. van Helden Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis Cytokine 47 2009 132 136
28. D. Ordway, M. Henao-Tamayo, C. Shanley, E.E. Smith, G. Palanisamy, and B. Wang Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis Clin Vaccine Immunol 15 2008 1248 1258
29. D. Ordway, G. Palanisamy, M. Henao-Tamayo, E.E. Smith, C. Shanley, and I.M. Orme The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig J Immunol 179 2007 2532 2541
30. D.J. Ordway, C.A. Shanley, M.L. Caraway, E.A. Orme, D.S. Bucy, and L. Hascall-Dove Evaluation of standard chemotherapy in the guinea pig model of tuberculosis Antimicrob Agents Chemother 54 2010 1820 1833